Nombre del producto:4-Amino-3-phenylquinazolin-2(3H)-one
IUPAC Name:4-amino-3-phenyl-2,3-dihydroquinazolin-2-one
| Unidad de embalaje | Stock disponible | Precio($) | Cantidad |
|---|---|---|---|
| CM216225-1g | 1-2 Weeks | ȐȺǶ |
|
|
|||
| Product Overview |
4-Amino-3-phenylquinazolin-2(3H)-one is a heterocyclic organic compound that has gained significant attention in the field of medicinal chemistry due to its potential therapeutic applications. This compound has been extensively studied for its biological activities, including its anticancer, antiviral, and antibacterial properties. |
| Synthesis and Application |
The most common method for synthesizing 4-Amino-3-phenylquinazolin-2(3H)-one is by reacting anthranilic acid with benzylidene acetone in the presence of a catalyst. Other methods include the reaction of anthranilic acid with 2-aminobenzophenone or 2-aminobenzaldehyde in the presence of a base. The yield of this compound is typically high, and the purity can be improved through recrystallization. 4-Amino-3-phenylquinazolin-2(3H)-one has been extensively studied for its potential therapeutic applications. It has been found to exhibit anticancer activity by inhibiting the growth of cancer cells and inducing apoptosis. Additionally, this compound has been found to possess antiviral properties and has been studied for its potential use in treating viral infections such as HIV and hepatitis B. Furthermore, it has been shown to exhibit antibacterial activity against various strains of bacteria, including Staphylococcus aureus and Escherichia coli. |
| Future Directions |
There are several future directions for the study of 4-Amino-3-phenylquinazolin-2(3H)-one. One potential direction is the development of more potent and selective analogs of this compound for use as anticancer or antiviral agents. Additionally, further studies are needed to fully understand the mechanism of action of this compound and its potential therapeutic applications. Finally, the use of this compound in combination with other drugs or therapies may enhance its efficacy and reduce potential toxicity. |
Buscar 
+86 21 5895 0110 
